VeriSign (VRSN) - FREE Research Report

Roach John D who is Director at VeriSign sold 333 shares at $59.74 on Jan. 3, 2014. Following this transaction, the Director owned 13,012 shares meaning that the stake was reduced by 2.5% with the 333-share transaction.

The shares most recently traded at $59.50, down $0.24, or 0.4% since the insider transaction. Historical insider transactions for VeriSign go as follows:

  • 24-Week # shares sold: 8,581

The average volume for VeriSign has been 1.2 million shares per day over the past 30 days. VeriSign has a market cap of $8.2 billion and is part of the technology sector and internet industry. Shares are up 0.1% year-to-date as of the close of trading on Friday.

VeriSign, Inc. provides Internet infrastructure services to various networks worldwide. It offers registry services that operate the authoritative directory of .com, .net, .cc, .tv, and .name domain names, as well as the back-end systems for various for all .gov, .jobs, and .edu domain names. The company has a P/E ratio of 26.9. Currently there are 2 analysts that rate VeriSign a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VRSN - FREE

TheStreet Quant Ratings rates VeriSign as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, revenue growth, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full VeriSign Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

'Mad Money' Lightning Round: Southwestern Energy, UnitedHealth, Celgene and More

Jim Cramer's 'Mad Money' Recap: Don't Worry About a Little Market Detour

2 Specialty Chemical Stocks With Breakout Potential

3 Stocks Improving Performance Of The Chemicals Industry

Analysts' Actions -- Activision, Garmin, Match, Sirius and More